Abstract:The synthesis of a range of 3-hydroxy-4(1H)-pyridinones with potential for the chelation of iron(III) is described. The pK(a) values of respective ligands and the stability constants of their iron(III) complexes are presented, The distribution coefficient values of a range of 48 hydroxypyridinones and their corresponding iron(III) complexes between l-octanol and MOPS buffer (pH 7.4) are reported. The range of log D-complex values covers 7 orders of magnitude. The results suggest the existence of a biphasic relationship between the distribution coefficient values of the chelator and the corresponding iron(III) complexes. For ligands with a log D-ligand = -1, a linear relationship exists with a value of the slope 2.53, whereas with ligands with a log D-ligand < -1, a linear relationship exists with a slope of 0.49. The reduced slope for the more hydrophilic molecules of the series offers some advantage for this type of hydroxypyridinone as the distribution coefficients for such complexes do not change so rapidly with increasing ligand hydrophilicity. The ability of selected 3-hydroxypyridinones to facilitate the excretion of iron in bile was investigated in non-iron-overloaded, bile duct-cannulated rats and in a [Fe-59]ferritin-loaded rat model. Both systems compare the ability of chelators to remove iron from the liver, the prime target organ in thalassemia. The N-(hydroxyalkyl)-3-hydroxypyridin-4-ones are demonstrated to be orally active under the in vivo conditions adopted. Thus both 1-(hydroxyalkyl)- and 1-(carboxyalkyl)pyridinones are able to remove iron from the liver. Although 1-(carboxyalkyl)hydroxypyridinones are active, they do not demonstrate any clear advantage over Deferiprone (1,2-dimethyl-3-hydroxypyridin-4-one). Indeed 1-(hydroxyalkyl)hydroxypyridinones which are known to be rapidly converted to 1-(carboxyalkyl)hydroxypyridinones are also marginally superior to Deferiprone. In contrast, 2-ethyl-1-(2'-hydroxyethyl)-3-hyaroxypyridin-4-one, which is not metabolized to the corresponding (carboxyalkyl)hydroxypyridinone, was found to be superior to Deferiprone and therefore deserves further consideration as an orally active iron chelator with potential for the treatment of iron overload associated with transfusion-dependent thalassemia.

Simultaneous round and Oval Window Fistulae in a Child

Multipurpose Iron-Chelating Ligands Inspired by Bioavailable Molecules

Chemistry and Biology of Siderophores from Marine Microbes

Efficient density functional theory directed identification of siderophores with increased selectivity towards indium and germanium

A New Approach to Characterize Siderophore-Type Ligands in Seawater by Solid Phase Synthesis and SPE-HPLC-ESI-MS/MS Analysis

Synthesis, characterization and evaluation of new anti-inflammatory iron charge transfer complexes

The iron(III) coordinating properties of citrate and α-hydroxycarboxylate containing siderophores

Biosynthesis of novel desferrioxamine derivatives requires unprecedented crosstalk between separate NRPS-independent siderophore pathways

Synthesis, Physicochemical Properties, and Evaluation of<i>N</i>-Substituted-2-alkyl-3-hydroxy-4(1<i>H</i>)-pyridinones<sup>†</sup>

Ferrocene and Organotin (IV) Conjugates Containing Amino Acids and Peptides: A Promising Strategy for Searching New Therapeutic and Diagnostic Tools

Molecular Cages as Encapsulants for the Stabilization of Reactive Iron-Sulfur Cofactor Models

Advances in the synthesis of enterobactin, artificial analogues and enterobactin-derived antimicrobial drug conjugates and imaging tools for infection diagnosis

[Microorganism Immobilization Device Using Artificial Siderophores]

Atomic-level design of biomimetic iron–sulfur clusters for biocatalysis

Preparation of Iron-Based Sulfides and Their Applications in Biomedical Fields

SIDERITE: Unveiling Hidden Siderophore Diversity in the Chemical Space Through Digital Exploration

Design of iron chelators with therapeutic application

3-hydroxypyridinone derivatives as metal-sequestering agents for therapeutic use

Application of the empirical force field to macrocyclic ion carriers, siderophores, and biomimetic analogs

Designing, DFT, Biological, & molecular docking analysis of new Iron(III) & Copper(II) complexes incorporating 1-{[-(2-Hydroxyphenyl)methylene]amino}-5,5-diphenylimidazolidine-2,4-dione (PHNS)

5-Hydroxypyran-4-one Derivatives As Potential Therapeutic Iron-Chelating Agents